The AnapnoGuard™ Endotracheal Tube is indicated for airway management by oral or nasal intubation of the trachea and for evacuation or drainage of the subglottic space.

Device Description

The AnapnoGuard™ Endotracheal Tube is a sterile, single-use device supplied with main lumen with a standard 15mm connector. Four lumens are embedded within tube walls. One is a standard lumen used for the inflation/deflation of the cuff. Two suction lumens are embedded in the dorsal side of the tube having spatially unified into one success above the cuff. The two suction lumens are unified into one external lumen. These lumens are used to evacuate secretions that accumulate above the cuff. A forth lumen is embedded on the ventral side of the tube having an inlet port above the cuff. It is used for a) venting the subglottis space during suction to avoid vacuum b) for saline (or other fluid) rinsing above the cuff to dilute the secretions and ease the suction c) for air sampling above the cuff to detect leakage of air from the lungs past the cuff. The AnapnoGuard ETT is comprised of the following components: Main lumen (PVC or Silicone), Cuff (Polyurethane for PVC tube and Silicone for Silicon tube), Cuff inflate/deflate lumen, Two suction lumens combined into one outside of the tube sealed with a cap, Venting/air and CO2 sampling lumen sealed with a cap, Murphy eye (with or without).

AI/ML Overview

The provided text describes the AnapnoGuard™ Endotracheal Tube and its substantial equivalence to predicate devices, thus demonstrating its safety and effectiveness. However, it does not contain specific acceptance criteria, a table of acceptance criteria vs. reported device performance, or detailed information about the studies that would allow for a complete answer to your request. The document focuses on regulatory compliance through substantial equivalence, which often relies on comparative analysis with existing, cleared devices rather than a new standalone clinical study with predefined acceptance criteria.

Therefore, I can extract and infer some information, but a complete table of acceptance criteria and device performance, as well as detailed study information, cannot be fully provided from the given text.

Here is what can be inferred and explicitly stated from the provided document:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state quantitative acceptance criteria or a table comparing them to reported device performance. Instead, it relies on demonstrating compliance with established standards and substantial equivalence to predicate devices. The "reported device performance" is summarized as being "as safe and effective as the cleared predicate devices" and that "no occlusion or any adverse events occurred during the study, airway stay open throughout study procedure."

Acceptance Criteria (Inferred from Standards & Claims)	Reported Device Performance (Summary)
Compliance with ISO 5361:1999 (Tracheal tubes)	AnapnoGuard™ Endotracheal Tube was tested and complies with this standard.
Compliance with ANSI/AAMI/ISO 11135-1:2007 (Sterilization)	AnapnoGuard™ Endotracheal Tube was tested and complies with this standard.
Compliance with AAMI TIR28:2001 (Sterilization)	AnapnoGuard™ Endotracheal Tube was tested and complies with this standard.
Compliance with ISO 14971-1:2007 (Risk Management)	AnapnoGuard™ Endotracheal Tube was tested and complies with this standard.
Compliance with ISO 10993-1:2003(E) (Biocompatibility)	AnapnoGuard™ Endotracheal Tube was tested and complies with this standard.
No occlusion or adverse events during intubation	In a preclinical study, "No occlusion or any adverse events occurred during the study, airway stay open throughout study procedure."
Safety and Effectiveness for intended use	Device is "as safe and effective as the cleared predicate devices." "Study has demonstrated that the AnapnoGuard ETT device is safe and effective for its intended use."
Performance in specific bench tests	The device underwent and presumably passed: Determination of Cuff Resting Diameter, Resistance to Cuff Herniation, Cuff Symmetry, Suction Safety Test, Resistance to tube collapse.
Substantial Equivalence to Predicate devices	Bench and preclinical testing demonstrated substantial equivalence, leading to FDA clearance.

2. Sample Size Used for the Test Set and Data Provenance

Sample Size:
- Pre-clinical study: 6 goats.
- Bench Tests: The sample sizes for each specific bench test (e.g., number of tubes tested for cuff resting diameter) are not provided.
Data Provenance: The preclinical study was conducted by Hospitech Respiration Ltd. The location of the animal study (e.g., country) is not specified. The study is referred to as "preclinical," which implies a prospective study in an animal model.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This information is not provided in the document. For a preclinical animal study, the "ground truth" would likely be established by veterinary specialists or researchers involved in the study, observing the animals and collecting physiological data. However, the document does not mention the number or qualifications of experts for this specific purpose.

4. Adjudication Method for the Test Set

This information is not provided in the document.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No, an MRMC comparative effectiveness study was not done. The document states, "Due to the pre-clinical study performed with the AnapnoGuard ETT device, the thorough performance tests and comprehensive clinical study performed by the cleared predicate device (Attachment No. 9), Hospitech believes that clinical studies are not required to determine the safety and efficacy of the device." This indicates reliance on predicate device data and preclinical/bench testing for the AnapnoGuard ETT, not a human reader study.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

This question is not applicable as the device is a physical medical device (endotracheal tube), not an algorithm or AI system.

7. The Type of Ground Truth Used

For the preclinical study: Observational data from animal intubation (e.g., "no occlusion or any adverse events occurred," "airway stay open"). This would be considered outcome data within the context of the animal model.
For bench tests: Measurements against established physical and performance standards (e.g., cuff diameter measurements, resistance tests). This is objective measurement data compared to specifications.
For substantial equivalence: Comparison against the characteristics and performance of the predicate devices.

8. The Sample Size for the Training Set

This question is not applicable as the device is a physical medical device, not an AI model that requires a training set.

9. How the Ground Truth for the Training Set Was Established

This question is not applicable as the device is a physical medical device, not an AI model.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows a logo for Hospitech Respiration. The logo features a stylized globe with horizontal lines and a large letter "H" superimposed on it. The text "Hospitech Respiration" is written below the globe in a simple font.

MAR - 2 2010

こ

510(K) SUMMARY

AnapnoGuard™ Endotracheal Tube

510(k) Number K Ω93 | 2 b

Applicant's Name: Hospitech Respiration Ltd. 20 Hamagshimim St. Kiryat Matalon, POB. 7970 Petach-Tikva, 49250 Israel TEL: (972)3-919-1648, FAX: (972)3-919-1649

Contact Person: Yoram Levy, Qsite 31 Haavoda St. Binyamina, Israel 30500 Tel (972)4-638-8837; Fax (972)4-638-0510 Yoram@qsitemed.com
Preparation Date: September 21, 2009

Trade Name: AnapnoGuard™ ETT

Device Type Tracheal Tube

Classification: Regulatory Name: tube, tracheal

Product Code: BTR

Regulation No: 21 CFR 868.5730

Class: II

Classification Panel: Anesthesiology

Device Description:

Hospitech AnapnoGuard ETT K093126 510k Response

{1}------------------------------------------------

Image /page/1/Picture/0 description: The image shows a logo for Hospitech Respiration. The logo features a globe-like design with horizontal and vertical lines, resembling a grid. In the center of the globe, there is a large letter 'H' in a bold, serif font. Below the globe and the letter 'H', the words 'Hospitech Respiration' are written in a serif font.

A forth lumen is embedded on the ventral side of the tube having an inlet port above the cuff. It is used for a) venting the subglottis space during suction to avoid vacuum b) for saline (or other fluid) rinsing above the cuff to dilute the secretions and ease the suction c) for air sampling above the cuff to detect leakage of air from the lungs past the cuff.

The AnapnoGuard ETT is comprised of the following components:

Main lumen (PVC or Silicone) ●
. Cuff (Polyurethane for PVC tube and Silicone for Silicon tube)
Cuff inflate/deflate lumen .
. Two suction lumens combined into one outside of the tube sealed with a cap
Venting/air and CO2 sampling lumen sealed with a cap. ●
Murphy eye (with or without) .

Intended Use Statement:

The AnapnoGuard™ Endotracheal Tube is indicated for airway management by oral or nasal intubation of the trachea and for evacuation or drainage of the subglottic space.

Predicate Devices: Substantial equivalence to the following predicate devices is claimed:

Device Name	Manufacturer	510k No	Date of approval
SealGuard EndotrachealTube	Covidien	K082520	Oct 2, 2008
Well Lead Endotrachealtube	Well Lead	K042683	Feb 18, 2005

Performance Standards

AnapnoGuard™ Endotracheal Tube was tested and complies with the following standards:

ISO 5361:1999 Anaesthetic and respiratory equipment --. Tracheal tubes and connectors
· ANSIIAAMIIISO 11135-1:2007 Sterilization of health care products - Ethylene oxide

Hospitech AnapnoGuard ETT K093126 510k Response

ટર્

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for Hospitech Respiration. The logo features a stylized globe shape with a large letter 'H' in the center. The text 'Hospitech Respiration' is written below the globe and letter.

AAMI TIR28:2001 Product adoption and process equivalency . for ethylene oxide sterilization
ISO 14971-1:2007 Risk management for medical devices ●
ISO 10993-1:2003(E), Biological evaluation of medical ● devices -- Part 1: Evaluation and testing

A detailed description appears in Section 14.

Bench Tests

AnapnoGuard™ Bench testing demonstrated that the Endotracheal Tube is as safe and effective as the cleared predicate devices.

The following bench tests were conducted:

Determination of Cuff Resting Diameter ●
Resistance to Cuff Herniation ●
Cuff Symmetry ●
Suction Safety Test .
. Resistance to tube collapse

Summary of Pre-Clinical and clinical study

Preclinical study was designed in order to evaluate the safety and effectiveness of using the AnapnoGuard ETT device as an endotracheal tube intended for airway management by oral or nasal intubation. Altogether 6 goats were intubated for 4 to 6 hours. No occlusion or any adverse events occurred during the study, airway stay open throughout study procedure. Study has demonstrated that the AnapnoGuard ETT device is safe and effective for its intended use (pre-clinical study summary is provided in attachment No. 10).

Due to the pre-clinical study performed with the AnapnoGuard ETT device, the thorough performance tests and comprehensive clinical study performed by the cleared predicate device (Attachment No. 9), Hospitech believes that clinical studies are not required to determine the safety and efficacy of the device.

Comparison to the Predicate Device

The AnapnoGuard™ Endotracheal Tube has the same intended use, general and specific indications and principles of operation as the cleared Covidien's SealGuard Endotracheal Tube (K082520). The material composition of both is the same; the lumens are made of PVC and the cuff of PU (polyurethane).

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows a logo for Hospitech Respiration. The logo features a stylized globe with a large letter "H" superimposed in the center. The text "Hospitech Respiration" is written below the globe and letter.

The minor differences between the AnapnoGuard and the SealGuard Endotracheal Tube do not raise any new questions of safety or efficacy. Moreover, bench and preclinical testing of the AnapnoGuard™ Endotracheal Tube (bench testing are provided in Attachments 7) demonstrated that the AnapnoGuard™ Endotracheal Tube is as safe and effective as the predicate devices. Thus, the AnapnoGuardTM Endotracheal Tube is substantially equivalent to the already cleared SealGuard Evac Endotracheal Tube.

The PVC of the AnapnoGuard™ Endotracheal Tube PVC model is identical to the PVC of the Well Lead Endotracheal Tube cleared in K042683 and the Silicone of the AnapnoGuard™ Endotracheal Tube Silicone model is identical to the silicone of the All-Silicone 2-Way and 3-Way Hematuria Catheter cleared in K021142

Hospitech AnapnoGuard ETT K093126 510k Response

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo features the department's seal, which includes an emblem with three stylized human figures in blue, representing health, services, and people. The seal is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

MAR 1 1 2010

Mr. Yoram Levy Regulatory Consultant Hospitech Respiration Limited 20 Hamagshimim Street Kiryat Matalon Petach Tikva 49348 ISRAEL

Re: K093126

Trade/Device Name: AnapnoGuard Endotracheal Tube Regulation Number: 21 CFR 868.5730 Regulation Name: Tracheal Tube Regulatory Class: II Product Code: BTR Dated: February 14, 2010 Received: March 2, 2010

Dear Mr. Levy:

This letter corrects our substantially equivalent letter of March 2, 2010 .

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{5}------------------------------------------------

Page 2 - Mr. Levy

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to

http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

h for

Susan Runner, DDS Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices. Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image shows a logo for Hospitech Respiration. The logo features a large letter H inside of a semi-circle. The semi-circle is surrounded by a dotted oval shape. Below the logo, the words "Hospitech Respiration" are written in a simple font.

INDICATIONS FOR USE STATEMENT

510(k) Number (if known):

Device Name:	AnapnoGuard™ Endotracheal Tube
Indications for Use:	The AnapnoGuard™ Endotracheal Tube is indicated for airwaymanagement by oral or nasal intubation of the trachea and forevacuation or drainage of the subglottic space.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF
NEEDED NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-off) Division of Anesthesiology, 510(k) Number

Device Evaluation (ODE)

(Division Sign-Off)

Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Number: K093126

1-2 AnapnoGuard™ Endotracheal Tube - 510k Notification

Regulation Number and Section

§ 868.5420 Ether hook.

(a)
Identification. An ether hook is a device that fits inside a patient's mouth and that is intended to deliver vaporized ether.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 868.9. If the device is not labeled or otherwise represented as sterile, it is exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.